droxidopa has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, S; Brull, A; Coll, M; Esteban, R; Ezkurdia, N; GenescĂ , J; Guardia, J; Martell, M; Raurell, I; Rodriguez, S | 1 |
1 other study(ies) available for droxidopa and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Topics: Animals; Antiparkinson Agents; Bile Ducts; Blood Pressure; Carbidopa; Carbon Tetrachloride; Disease Models, Animal; Diuresis; Droxidopa; Enzyme Inhibitors; Hemodynamics; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Natriuresis; Nitric Oxide Synthase Type III; Phosphorylation; Portal Vein; Propranolol; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; rho-Associated Kinases; Signal Transduction; Urodynamics; Vascular Resistance | 2012 |